当前位置：首页 > 文献互助 > 互助详情

Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer复制

用户jv6QuM3seMGQ 1小时前 9 10 待确认 帖子自动结束时间: 2026-05-25 15:06:27

1. 请及时下载文件确认是否正确, 系统将在 2026-05-27 15:35:52 删除文件

2. 如若文件有误请驳回应助文件, 求助状态即回到求助中

3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1056/nejmoa2505783复制

文献链接: http://www.nejm.org/doi/10.1056/NEJMoa2505783复制

其他信息:

出版社: Massachusetts Medical Society
作者: Brian M. Wolpin; Wungki Park; Ignacio Garrido-Laguna; Alexander Spira; Alexander Starodub; David Sommerhalder; Salman R. Punekar; Minal Barve; Meredith Pelster; Benjamin Herzberg; Nilofer S. Azad; Joel Randolph Hecht; Sai Hong Ignatius Ou; Tong Lin; Sumit Kar; Lin Tao; Rashmi Vora; Aparna Hegde; Kyaw Aung; David S. Hong

上一篇：(FEV3-FEV1)/FVC: A Terminal-Airflow Variable for Airway Hyperresponsiveness and Inflammation Prediction in Patients With Symptoms Despite Preserved Spirometry

下一篇：A patent review of LPAR1 antagonists (2010 – present)

互助时间线

2026-05-20 15:35:52 [上传文件]

小书虫2023上传了文件(pdf 494.01 KB), 求助状态变成 待确认

2026-05-20 15:06:27 [发起求助]

最新发布的求助

Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C–Mutated Tumors 21分钟前
Activin receptor-like kinase 5 (ALK5) inhibitors: a patent review (2013-present) 27分钟前
A patent review of LPAR1 antagonists (2010 – present) 41分钟前
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer 1小时前
(FEV3-FEV1)/FVC: A Terminal-Airflow Variable for Airway Hyperresponsiveness and Inflammation Prediction in Patients With Symptoms Despite Preserved Spirometry 1小时前
Single-inhaler triple therapy improves small airway dysfunction in moderate to severe asthma and asthma-COPD overlap: a retrospective cohort study 1小时前
High occurrence of antiphospholipid antibody-associated thromboembolism in systemic lupus erythematosus with significant pulmonary hypertension: A monocentric retrospective study in southern taiwan 1小时前
A Single Site, Open Label Clinical Trial, Evaluating the Duration, Efficacy, and Safety of a Novel Lip Plumper 1小时前
Repurposed versus disease-specific medicinals for the prophylaxis of migraine: an updated systematic review 1小时前
Abstract LB262: HSK38008: An oral AR-V7 degrader for metastatic castration-resistant prostate cancer 1小时前
The Medicinal Chemist's Guide to Solving ADMET Challenges 2小时前
A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor-Positive Recurrent Endometrial Cancer 2小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com